一个基于的益生菌补充剂试点研究在克罗恩病患者中进行
Haim Leibovitzh1,2, Naomi Fliss Isakov1,3, Lael Werner1,2
1Department of Gastroenterology and Liver Diseases, IBD Center, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Journal of dietary supplements
|May 2, 2025
概括
基于的益生菌补充剂在克罗恩病 (CD) 患者中显示出临床改善. 这种干预改变了肠道微生物群,增加了有益的短链脂肪酸产生细菌,并影响了微生物通路.
科学领域:
- 胃肠病学和肝病学
- 微生物学 微生物学
- 营养科学 营养科学
背景情况:
- 关于在西方人群中治疗克罗恩病 (CD) 的基于的益生菌补充剂的数据有限.
- 了解益生菌对CD肠道微生物群的影响对于开发新型治疗策略至关重要.
研究的目的:
- 评估一种基于的益生菌 ("Mycodigest") 在患有轻度至中度CD的患者的临床疗效.
- 评估"Mycodigest"对便微生物组成和功能的影响.
主要方法:
- 进行了一项随机,双盲,安慰剂控制的试点试验.
- 使用哈维-布拉德肖指数,C反应蛋白和便calprotectin评估了临床疗效.
- 用DNA枪甲基因组测序分析便样本,以评估微生物组的变化.
主要成果:
- 与安慰剂 (16.7%,p=0.035) 相比,在"Mycodigest"组 (80%) 观察到显著更高的临床响应率.
- 干预后,25种细菌物种的丰富差异,包括短链脂肪酸生产者的增加,如Parabacteroides distasonis和Faecalimonas umbilicata.
- 在服用"Mycodigest"补充剂后,参与异oprenoid代谢的两个微生物途径得到了上调.
结论:
- 基于的益生菌补充剂在CD患者中显示出临床改善.
- 这些临床益处可能与便微生物组合和功能的有利变化有关,包括增加的SCFA产生细菌.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
223
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
223
What is Monogastric Digestion?
69.6K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
69.6K
Drugs for Treatment of Constipation-Predominant IBS
109
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
109


